Discovery - University of Dundee - Online Publications

Library & Learning Centre

The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression

Standard

The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression. / Bernard, H.; Garmy-Susini, B.; Ainaoui, N.; Van Den Berghe, L.; Peurichard, A.; Javerzat, S.; Bikfalvi, A.; Lane, D.P.; Bourdon, J.C.; Prats, A.-C. (Lead / Corresponding author).

In: Oncogene, Vol. 32, No. 17, 25.04.2013, p. 2150-2160.

Research output: Contribution to journalArticle

Harvard

Bernard, H, Garmy-Susini, B, Ainaoui, N, Van Den Berghe, L, Peurichard, A, Javerzat, S, Bikfalvi, A, Lane, DP, Bourdon, JC & Prats, A-C 2013, 'The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression' Oncogene, vol 32, no. 17, pp. 2150-2160.

APA

Bernard, H., Garmy-Susini, B., Ainaoui, N., Van Den Berghe, L., Peurichard, A., Javerzat, S., Bikfalvi, A., Lane, D. P., Bourdon, J. C., & Prats, A-C. (2013). The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression. Oncogene, 32(17), 2150-2160doi: 10.1038/onc.2012.242

Vancouver

Bernard H, Garmy-Susini B, Ainaoui N, Van Den Berghe L, Peurichard A, Javerzat S et al. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression. Oncogene. 2013 Apr 25;32(17):2150-2160.

Author

Bernard, H.; Garmy-Susini, B.; Ainaoui, N.; Van Den Berghe, L.; Peurichard, A.; Javerzat, S.; Bikfalvi, A.; Lane, D.P.; Bourdon, J.C.; Prats, A.-C. (Lead / Corresponding author) / The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.

In: Oncogene, Vol. 32, No. 17, 25.04.2013, p. 2150-2160.

Research output: Contribution to journalArticle

Bibtex - Download

@article{4037e8d7916b43b29db3562847824009,
title = "The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression",
author = "H. Bernard and B. Garmy-Susini and N. Ainaoui and {Van Den Berghe}, L. and A. Peurichard and S. Javerzat and A. Bikfalvi and D.P. Lane and J.C. Bourdon and A.-C. Prats",
year = "2013",
volume = "32",
number = "17",
pages = "2150--2160",
journal = "Oncogene",
issn = "0950-9232",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression

A1 - Bernard,H.

A1 - Garmy-Susini,B.

A1 - Ainaoui,N.

A1 - Van Den Berghe,L.

A1 - Peurichard,A.

A1 - Javerzat,S.

A1 - Bikfalvi,A.

A1 - Lane,D.P.

A1 - Bourdon,J.C.

A1 - Prats,A.-C.

AU - Bernard,H.

AU - Garmy-Susini,B.

AU - Ainaoui,N.

AU - Van Den Berghe,L.

AU - Peurichard,A.

AU - Javerzat,S.

AU - Bikfalvi,A.

AU - Lane,D.P.

AU - Bourdon,J.C.

AU - Prats,A.-C.

PY - 2013/4/25

Y1 - 2013/4/25

N2 - The tumour suppressor p53, involved in DNA repair, cell cycle arrest and apoptosis, also inhibits blood vessel formation, that is, angiogenesis, a process strongly contributing to tumour development. The p53 gene expresses 12 different proteins (isoforms), including TAp53 (p53 (or p53a), p53ß and p53?) and ?133p53 isoforms (?133p53a, ?133p53ß and ?133p53?). The ?133p53a isoform was shown to modulate p53 transcriptional activity and is overexpressed in various human tumours. However, its role in tumour progression is still unexplored. In the present study, we examined the involvement of ?133p53 isoforms in tumoural angiogenesis and tumour growth in the highly angiogenic human glioblastoma U87. Our data show that conditioned media from U87 cells depleted for ?133p53 isoforms block endothelial cell migration and tubulogenesis without affecting endothelial cell proliferation in vitro. The ?133p53 depletion in U2OS osteosarcoma cells resulted in a similar angiogenesis blockade. Furthermore, using conditioned media from U87 cells ectopically expressing each ?133p53 isoform, we determined that ?133p53a and ?133p53? but not ?133p53ß, stimulate angiogenesis. Our in vivo data using the chicken chorio-allantoic membrane and mice xenografts establish that angiogenesis and growth of glioblastoma U87 tumours are inhibited upon depletion of ?133p53 isoforms. By TaqMan low-density array, we show that alteration of expression ratio of ?133p53 and TAp53 isoforms differentially regulates angiogenic gene expression with ?133p53 isoforms inducing pro-angiogenic gene expression and repressing anti-angiogenic gene expression.Oncogene advance online publication, 25 June 2012; doi:10.1038/onc.2012.242.

AB - The tumour suppressor p53, involved in DNA repair, cell cycle arrest and apoptosis, also inhibits blood vessel formation, that is, angiogenesis, a process strongly contributing to tumour development. The p53 gene expresses 12 different proteins (isoforms), including TAp53 (p53 (or p53a), p53ß and p53?) and ?133p53 isoforms (?133p53a, ?133p53ß and ?133p53?). The ?133p53a isoform was shown to modulate p53 transcriptional activity and is overexpressed in various human tumours. However, its role in tumour progression is still unexplored. In the present study, we examined the involvement of ?133p53 isoforms in tumoural angiogenesis and tumour growth in the highly angiogenic human glioblastoma U87. Our data show that conditioned media from U87 cells depleted for ?133p53 isoforms block endothelial cell migration and tubulogenesis without affecting endothelial cell proliferation in vitro. The ?133p53 depletion in U2OS osteosarcoma cells resulted in a similar angiogenesis blockade. Furthermore, using conditioned media from U87 cells ectopically expressing each ?133p53 isoform, we determined that ?133p53a and ?133p53? but not ?133p53ß, stimulate angiogenesis. Our in vivo data using the chicken chorio-allantoic membrane and mice xenografts establish that angiogenesis and growth of glioblastoma U87 tumours are inhibited upon depletion of ?133p53 isoforms. By TaqMan low-density array, we show that alteration of expression ratio of ?133p53 and TAp53 isoforms differentially regulates angiogenic gene expression with ?133p53 isoforms inducing pro-angiogenic gene expression and repressing anti-angiogenic gene expression.Oncogene advance online publication, 25 June 2012; doi:10.1038/onc.2012.242.

UR - http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-84862515375&md5=758b6ac884f3171c8a85a7d07b6116f0

UR - http://www.nature.com/onc/journal/v32/n17/full/onc2012242a.html

U2 - 10.1038/onc.2012.242

DO - 10.1038/onc.2012.242

M1 - Article

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 17

VL - 32

SP - 2150

EP - 2160

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy